Home › Teva and Takeda Agree to Commercialize Rasagiline for Parkinson's Disease Treatment in Japan
 

Keywords :   


Teva and Takeda Agree to Commercialize Rasagiline for Parkinson's Disease Treatment in Japan

2014-04-28 04:37:19| Biotech - Topix.net

Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement allowing Takeda to commercialize Teva's innovative treatment for Parkinson's disease, rasagiline* in Japan.

Tags: in japan agree treatment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Flint Group retains EcoVadis Silver Medal for 2024
15.05Mark Andy hosts student workshop in Poland
15.05Kenvue Launches Aveeno Baby Healthy Start Wash and Balm
15.05Royal Mail owner poised to accept 3.5bn takeover bid
15.05Gold Bond Named Official Body Skin Sponsor of Sports Illustrated Swimsuit\'s 60th Anniversary Issue
15.05Dunn-Edwards Reveals New Multifamily Color Collection
15.05Kimberly-Clark Names Chief Growth Officer
15.05TV Personality Lo Bosworth and BIC Soleil Escape Razors Launch Limited-Edition Five Senses Shave Kit
More »